PMDA drug package insert
ウラリット−U配合散
PMDA Prescription drug · 日本ケミファ株式会社 · package insert Dec 2, 2024
Key facts
| Brand names | ウラリット−U配合散, ウラリット配合錠 |
|---|---|
| Nonproprietary names | クエン酸カリウム・クエン酸ナトリウム水和物 |
| Companies | 製造販売元／日本ケミファ株式会社, 提携／マダウス社 |
| Product type | Prescription drug |
| Therapeutic category | アルカリ化療法剤－酸性尿・アシドーシス改善－ |
| Therapeutic category codes | 873949 |
| YJ codes | 3949101A1149, 3949101F1073 |
| Approval numbers | 22100AMX00517000, 22100AMX00518000 |
| Package insert edition | 第2版 |
| Package insert date | Dec 2, 2024 |
| PMDA document key | 530213_3949101A1149_1 |
| PMDA company code | 530213 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: